IQM Launches HPC Integration Service to Accelerate Hybrid Quantum-HPC Adoption
12.5.2026 10:00:00 EEST | Business Wire | Press release
IQM Quantum Computers today launched HPC Integration Service, a turnkey solution that enables its IQM Radiance quantum computers to operate as a slurm node inside high-performance computing (HPC) environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512187465/en/
IQM Radiance quantum computer (right) co-located with classical HPC infrastructure (left) in a data center environment.
Using this widely adopted HPC workflow, IQM aims at accelerating adoption of hybrid quantum-classical computing across enterprises and research institutions. Slurm is the open-source workload manager used by most of the world’s leading supercomputing centers for its scalability and flexibility.
The integration service makes quantum a scheduled resource alongside central processing units (CPUs) and graphics processing units (GPUs), removing the integration work that has slowed adoption.
In addition, the service is built on IQM´s Quantum Device Management Interface (QDMI), an open-source standardization layer that simplifies the vendor-specific software interfaces that have fragmented quantum integration to date.
The new HPC Integration Service has been demonstrated in a paper on arXiv co-authored with researchers at the Munich Quantum Software Company (MQSC) and is already running in production at the Leibniz Supercomputing Centre (LRZ) in Germany, where IQM has installed four quantum computers.
“We have been hearing about an integration bottleneck from HPC customers for years,” said Jan Goetz, CEO and Co-founder of IQM Quantum Computers. “HPC integration is important work and by removing the complexity, end-users can focus on running quantum workloads instead on spending time on programming new routines. This is what production quantum means to us. Quantum you own, operate, and build value on. Real infrastructure inside real environments, doing real work.”
Quantum computers have been deployed at customer sites for several years, but once installed, most of them have operated next to the HPC software stack rather than inside them. Every deployment required custom integration work that the next deployment could not reuse. The new HPC Integration Service unifies the software stack, allowing customers to focus on use-case execution.
The HPC Integration Service closes the gap by enabling users to submit quantum jobs through the same interface and scheduler they use for CPUs and GPUs. Researchers can run benchmarks across systems using tools they already know, while system teams keep their existing operating model.
“Our vision has always been the seamless integration of quantum computing into existing HPC environments, where users can run applications without concern for the underlying hardware. The Quantum Device Management Interface, as part of the Munich Quantum Software Stack, is a key step toward this goal. We are proud to see innovations developed within Munich Quantum Valley now being adopted by IQM as a key player in the quantum world to enable hybrid quantum-HPC workloads in real environments,” said Prof Dieter Kranzlmüller, Chairman of the Board of Directors, Leibniz Supercomputing Centre.
IQM has on-premises systems operating at four of the world’s top 10 supercomputing centres and has sold more quantum systems than any other manufacturer. The company’s ambition is to be the foundation that customers build their quantum capability on.
In February, IQM announced plans to go public through a business combination with Real Asset Acquisition Corp. (Nasdaq: RAAQ). Following the close of the transaction, the company is expected to list on a major U.S. stock exchange, with a dual listing on the Helsinki Stock Exchange under consideration.
About IQM Quantum Computers:
IQM Quantum Computers is the global leader in superconducting quantum computers, delivering full-stack quantum systems and cloud platform access to research institutions, universities, high-performance computing centers, and national laboratories worldwide. IQM's on-premises deployment model gives customers direct ownership and control of their quantum infrastructure. Founded in 2018, headquartered in Finland, it has over 350 employees. IQM operates across Europe, Asia, and North America. IQM has announced its plans to become the first publicly listed European quantum company on a major U.S. stock exchange by merging with Real Asset Acquisition Corp. (Nasdaq: RAAQ); with a dual listing on the Helsinki Stock Exchange also under consideration.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260512187465/en/
Contacts
IQM Media contact:
Email: press@meetiqm.com
Mobile: +358 (0) 50 479 0845
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Paymentology Raises $175 Million co-led by Apis Partners and Aspirity Partners to Support Next Phase of Growth12.5.2026 10:01:00 EEST | Press release
Paymentology, the leading global issuer-processor, today announced a $175 million investment co-led by Apis Partners (”Apis”), a private equity firm specialising in financial infrastructure and services, and Aspirity Partners (“Aspirity”), a pan-European Private Equity firm focused on Financial Technology & Services and Enterprise Technology & Connectivity Services. The investment will support Paymentology’s continued global expansion, product development and strengthening of its team, as the company builds on strong demand for modern issuer processing on a global scale. The transaction brings together two investors with deep experience in the payments industry and a shared focus on advancing payments infrastructure, united by the view that issuer processing represents one of the most significant opportunities in the sector. For Apis, the investment, made by Apis Growth Fund III1, marks the firm’s 16th payments investment. Both Apis and Aspirity will draw on their deep sector and globa
Visa Flexible Credential Brings More Flexible Ways to Pay to Zilch Cardholders in the UK12.5.2026 10:00:00 EEST | Press release
Visa, a world leader in digital payments, Zilch and Thredd today announced the introduction of Visa Flexible Credential (VFC) on Zilch cards in the UK, enabling more flexible ways to pay through a single, familiar card experience. Demand for flexible payment experiences continues to grow. Many people no longer think in fixed terms such as debit or credit, instead wanting the ability to choose what works best for a specific purchase in the moment. In the UK, 87% of people surveyed say flexible payment options support their financial or lifestyle goals1. Visa Flexible Credential is designed to support this shift, helping issuers offer more choice through one familiar card that already works at more than 150 million merchant locations worldwide. The new capability allows different payment options to sit behind one card or digital credential, giving cardholders greater choice and control while preserving the familiarity of tapping or paying as they always have. Visa Flexible Credential is
AMP IT Announces New Funding Round to Scale Its Private EV Charging as a Service in Switzerland and Beyond12.5.2026 09:43:00 EEST | Press release
AMP IT, a Geneva-based energy and mobility company, today announced the successful completion of a new funding round to accelerate the deployment of its private EV charging and energy management platform across Switzerland and international markets. Founded in 2021, AMP IT develops, finances, installs, and operates smart EV charging infrastructure for residential buildings, commercial real estate, and corporate fleets. Through its charging-as-a-service model, the company combines infrastructure with its proprietary software, AMP IT Hub, delivering a fully integrated energy solution. The latest funding round, supported notably by the Swiss Technology Fund, brings AMP IT’s total funding to €7 million since inception. The capital will support operational scaling, further development of its software platform, and expansion into selected European markets. “Users are increasingly looking for solutions that are simple, efficient, and affordable which is exactly what we provide,” said Florian
New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden12.5.2026 09:30:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new analyses from the HELIOS-B Phase 3 study of vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM), adding to the growing body of evidence supporting vutrisiran and reinforcing the durability of transthyretin (TTR) knockdown and its well-characterized safety profile. Vutrisiran is the first and only TTR silencer approved for ATTR-CM that is designed to deliver rapid knockdown of TTR at the source. The data presented at Heart Failure 2026, the annual congress of the Heart Failure Association of the European Society of Cardiology, show consistent clinical benefit across patient populations commonly encountered in clinical practice, including those with a high disease burden, supporting its use as a first-line treatment option for this rapidly progressive and life-threatening disease. “The analyses presented at Heart Failu
Merz Therapeutics’ Activities at ISPRM 2026 Highlight the Importance of Patient-Centric Management in Upper and Lower Limb Spasticity: From Goal Setting to Optimal Dosing for Better Patient Outcomes12.5.2026 09:00:00 EEST | Press release
Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced it will present 11 scientific abstracts at the International Society of Physical and Rehabilitation Medicine (ISPRM) 2026 World Congress. Taking place from May 17th to May 21st in Vancouver, Canada, the presentations will feature key data on optimal dosing strategies, immunogenicity and the potential for sustained long-term treatment response with XEOMIN® (incobotulinumtoxinA), underscoring the company's commitment to advancing the science behind durable clinical outcomes in neurorehabilitation. "Our presence at ISPRM underscores our deep commitment to advancing the science behind improved patient care," said Stefan König, CEO, Merz Therapeutics. "We believe that by furthering the understanding of long-term treatment efficacy, we can empower clinicians to better support people affected in achieving their functional goals. Our patient-centric research complements this by ensuring we never lose sig
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom